ARCA biopharma, Inc (ABIO)

Etorro trading 970x250

About ARCA biopharma, Inc

ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase 2 clinical trial for the treatment of diseases caused by ribonucleic acid viruses initially focusing on COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase 2 trial for the treatment of atrial fibrillation in patients with chronic heart failure (HF). The company also engages in the development of AB171, a thiol-containing derivative isosorbide mononitrate for the treatment of HF and peripheral arterial disease. ARCA biopharma, Inc. is headquartered in Westminster, Colorado. Address: 10170 Church Ranch Way, Westminster, CO, United States, 80021

ARCA biopharma, Inc News and around…

Latest news about ARCA biopharma, Inc (ABIO) common stock and company :

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
08 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19
16 Sep, 2021 FinancialContent
ARCA biopharma to Present at the Q3 Virtual Investor Summit on August 18th
16 Aug, 2021 FinancialContent
ARCA biopharma to Present at the Q3 Virtual Investor Summit on August 18th
16 Aug, 2021 Yahoo! Finance

WESTMINSTER, Colo., Aug. 16, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced that Jeff Dekker, Chief Financial Officer, will present at the Q3 Virtual Investor Summit being held August 17-18, 2021. ARCA is scheduled to present on Wednesday, August 18, 2021 at 1:15 PM ET. Management will be available for one-on-one meetings to b

ARCA biopharma Inc. (NASDAQ: ABIO) Featured in Coverage of Investor Summit Group’s Q3 Virtual Event
13 Aug, 2021 FinancialContent
We Think ARCA biopharma (NASDAQ:ABIO) Can Afford To Drive Business Growth
12 Aug, 2021 Yahoo! Finance

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

ARCA biopharma Announces Submission of PCT Patent Application for the Treatment of Coronavirus Infection and Associated Coagulopathy with rNAPc2
09 Aug, 2021 FinancialContent
ARCA biopharma Announces Second Quarter 2021 Financial Results and Provides Corporate Update
04 Aug, 2021 FinancialContent
12 Health Care Stocks Moving In Thursday's Intraday Session
29 Jul, 2021 FinancialContent

Gainers NanoVibronix (NASDAQ:NAOV) shares moved upwards by 38.21% to $2.64 during Thursday's regular session. Trading volume for ...

Gencaro Atrial Fibrillation Phase 2B Results Selected for Publication in Circulation: Arrhythmia and Electrophysiology
28 Jul, 2021 FinancialContent
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
20 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

64 Biggest Movers From Yesterday
14 Jul, 2021 FinancialContent

Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares climbed 128.8% to settle at $9.06 on Tuesday. Red Cat Holdings, ...

ARCA biopharma Provides Update on ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19
13 Jul, 2021 FinancialContent
ARCA biopharma to Present at Access to Giving Virtual Investor Conference on July 13th
09 Jul, 2021 FinancialContent
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021
08 Jul, 2021 Yahoo! Finance

RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13th \- 15th, 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period as well as 1x1 meetings with qualified investors throughout the event.

Best Reddit Penny Stocks to Buy Now? 7 for Your July Small-Caps List
07 Jul, 2021 FinancialContent
ARCA biopharma Announces rNAPc2 COVID-19 Patent Assignment Agreement
07 Jul, 2021 FinancialContent
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
12 May, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

ARCA biopharma Announces First Quarter 2021 Financial Results and Provides Corporate Update
11 May, 2021 FinancialContent
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
07 May, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Christopher Graybill Joins ARCA as Vice President, Clinical Development
05 May, 2021 FinancialContent
ARCA biopharma Announces C. Jeff Dekker to be Appointed Chief Financial Officer
03 May, 2021 FinancialContent
Interesting ABIO Call Options For May 21st
22 Mar, 2021 FinancialContent

Investors in ARCA biopharma Inc (ABIO) saw new options become available this week, for the May 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ABIO options chain for the new May 21st contracts and identified the following call contract of particular interest.

ARCA biopharma Announces 2020 Financial Results and Provides Corporate Update
18 Mar, 2021 FinancialContent
First Week of ABIO April 16th Options Trading
23 Feb, 2021 FinancialContent

Investors in ARCA biopharma Inc (ABIO) saw new options become available this week, for the April 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ABIO options chain for the new April 16th contracts and identified the following call contract of particular interest.

Here's Why We're Not Too Worried About ARCA biopharma's (NASDAQ:ABIO) Cash Burn Situation
13 Feb, 2021 Yahoo! Finance

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

ARCA Biopharma: COVID Treatment Phase 2B Data Coming In 2nd Quarter
05 Feb, 2021 FinancialContent

While extremely speculative, this biotech may be worth a shot for an explosive move, if the data is positive.

Best Penny Stocks To Buy Right Now? 5 For Your January Watch List
19 Jan, 2021 FinancialContent
First Week of September 17th Options Trading For ARCA biopharma (ABIO)
15 Jan, 2021 FinancialContent

Investors in ARCA biopharma Inc (ABIO) saw new options become available this week, for the September 17th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 245 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

Looking For Penny Stocks To Buy Now? 4 Biotech Stocks To Watch
22 Dec, 2020 FinancialContent

ARCA biopharma, Inc (ABIO) is a NASDAQ Common Stock listed in , ,

970x250